跳至主要内容
临床试验/ACTRN12617001001381
ACTRN12617001001381已完成未知

Randomised Controlled Trial on the effect of lifestyle intervention enabled by mobile technologies versus standard treatment to facilitate weight loss in patients with Non-alcoholic Fatty Liver Disease

im Su Lin0 个研究点目标入组 108 人开始时间: 2017年7月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
21 Years 至 70 Years(—)
性别
All

入选标准

  • The study is conducted in Singapore, at National University Hospital.
  • The inclusion criteria includes:
  • - Adult patients adults above 21-70 years old who have been diagnosed with NAFLD, confirmed by the presence of steatosis in the liver on ultrasound.
  • - Have BMI greater and equal to 23 kg/m2
  • - Own a smart-phone with data plan
  • - English-speaking
  • - Willing to consent to the study

排除标准

  • Patients will be excluded if they meet the following criteria:
  • - Consumption of more than 1.5 times the limit of alcohol recommended for the population (alcohol dose 15 g/week for women and 30 g/week for men)
  • - no serologic evidence of previous hepatitis B or C infection, chronic liver disease or cirrhosis or concomitant liver diseases
  • - pregnant
  • - on hepatotoxic medication
  • - poorly controlled diabetes mellitus (HbA1c > 10%), diabetes needing insulin,
  • - recent cardiovascular event in the past 6 months, known heart failure
  • - stage 4 and above kidney disease
  • - untreated hypothyroidism, depression
  • - mentally challenged
  • - biochemically recognized systemic diseases
  • - unwilling to provide informed consent

研究者

发起方
im Su Lin

相似试验